Isomorphic Labs raised $600 million in its first external funding round to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas.

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...

Most people start businesses to make more money. Mark Cuban? He's already got the billionaire badge. Now he's out to prove ...

With local multibillion-dollar mega-projects such as the Gordie Howe International Bridge and the NextStar Energy battery ...

Foreign leaders were quick to criticize the tariffs, a sign that Trump could be intensifying a broader trade war that could ...

Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...

The patient advocacy startup is set to be valued at more than $300 million after the Series B round, Business Insider has ...

Discover how pharmaceutical industry-funded drug trials are creating jobs and driving economic growth in the Buckeye State.

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

When it comes to antibiotic stewardship and clinical care, Brad Spellberg, MD, just wants to see the data.

Artificial intelligence continues stirring things up in chemistry. To wit: Y Combinator-backed Cambridge, U.K.-based ...

[BENGALURU] Swedish fintech company Klarna on Friday (Mar 14) reported a 24 per cent surge in 2024 revenue, as the buy now, pay later (BNPL) pioneer made public its paperwork for a long-awaited stock ...